Complement C7 and clusterin form a complex in circulation

Front Immunol. 2024 Jan 25:15:1330095. doi: 10.3389/fimmu.2024.1330095. eCollection 2024.

Abstract

Introduction: The complement system is part of innate immunity and is comprised of an intricate network of proteins that are vital for host defense and host homeostasis. A distinct mechanism by which complement defends against invading pathogens is through the membrane attack complex (MAC), a lytic structure that forms on target surfaces. The MAC is made up of several complement components, and one indispensable component of the MAC is C7. The role of C7 in MAC assembly is well documented, however, inherent characteristics of C7 are yet to be investigated.

Methods: To shed light on the molecular characteristics of C7, we examined the properties of serum-purified C7 acquired using polyclonal and novel monoclonal antibodies. The properties of serum‑purified C7 were investigated through a series of proteolytic analyses, encompassing Western blot and mass spectrometry. The nature of C7 protein-protein interactions were further examined by a novel enzyme-linked immunosorbent assay (ELISA), as well as size‑exclusion chromatography.

Results: Protein analyses showcased an association between C7 and clusterin, an inhibitory complement regulator. The distinct association between C7 and clusterin was also demonstrated in serum-purified clusterin. Further assessment revealed that a complex between C7 and clusterin (C7-CLU) was detected. The C7-CLU complex was also identified in healthy serum and plasma donors, highlighting the presence of the complex in circulation.

Discussion: Clusterin is known to dissociate the MAC structure by binding to polymerized C9, nevertheless, here we show clusterin binding to the native form of a terminal complement protein in vivo. The presented data reveal that C7 exhibits characteristics beyond that of MAC assembly, instigating further investigation of the effector role that the C7-CLU complex plays in the complement cascade.

Keywords: circulation; clusterin; complement; complement C7; complex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clusterin*
  • Complement Activation
  • Complement C7* / metabolism
  • Complement Membrane Attack Complex / metabolism
  • Complement System Proteins / metabolism

Substances

  • Complement C7
  • Clusterin
  • Complement System Proteins
  • Complement Membrane Attack Complex

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the doctoral program of excellence HOROS [Austrian Science Fund, FWF, Vienna, Austria, ZFW12530, to PG (guest lecturer), M-OS (advisor), MG (administrator), MM, and RW (coordinator)], the Marie Skłodowska Curie action CORVOS (EC Horizon 2020 Framework Programme H2020-MSCA-ITN-2019, 860044, to MM, ET, PG, ZP and RW), the Land of Tirol (WF-F.17258/10-2020, to RW), the Carlsberg Foundation (CF20-476 0045, to PG), the Novo Nordisk Foundation (NFF205A0063505 and NNF20SA0064201, to PG), the Svend Andersen Research Foundation (SARF2021, to PG). AR was funded by a BRIDGE - Translational Excellence Programme grant funded by the Novo Nordisk Foundation (NNF18SA0034956).